Investing
Bayer ordered to pay $3.5 million in latest Roundup weedkiller trial
© Reuters. FILE PHOTO: Logo of Bayer AG is pictured at the annual results news conference of the German drugmaker in Leverkusen, Germany February 27, 2019. REUTERS/Wolfgang Rattay/File Photo
By Brendan Pierson
(Reuters) – Bayer (OTC:) was ordered on Tuesday to pay nearly $3.5 million by a Philadelphia jury that found the company’s Roundup weedkiller caused a woman’s cancer, the company said, the latest in a string of trial losses for the company as it tries to fend off thousands of similar lawsuits.
The verdict marks the fifth consecutive loss for Bayer, but it is much smaller than recent verdicts against the company that total $2 billion. The German conglomerate has faced pressure from some investors to reach a speedy settlement of the litigation in order to avoid further hefty trial verdicts.
Read the full article here
-
Side Hustles6 days ago
Microsoft Is About to Begin Job Cuts. Here’s Why.
-
Make Money5 days ago
10 Critical Questions to Ask Your Financial Advisor Now
-
Make Money4 days ago
10 Ways to Make Money As a Graphic Designer
-
Investing6 days ago
What CMOs Need to Know About AI Adoption in Marketing Teams
-
Personal Finance3 days ago
If you are 60 years old, new 401(k) rules could save you money
-
Investing4 days ago
Could Easier Cancellations Build Customer Loyalty?
-
Investing5 days ago
Airbus keeps top spot with 766 jet deliveries in 2024 By Reuters
-
Side Hustles6 days ago
JPMorgan to Implement a Five-Day Return-to-Office Mandate